Cerebral Prescription and Intake Process: How It Works, What to Expect

How the Cerebral Intake and Prescription Process Works

Cerebral's public site describes therapy, medication if prescribed, or a combination of services. The exact enrollment screens, price, appointment availability, insurance network, and clinician type can change by state and plan. Treat the terms displayed for your address and selected service as authoritative rather than relying on a national price quoted by a review site [1].

A typical medication-management pathway includes:

1. creating an account and entering location, identity, contact, and payment or insurance information;
2. completing questions about symptoms, medical history, current medicines, allergies, substance use, safety, and treatment goals;
3. scheduling a remote visit with an appropriately licensed clinician;
4. completing a diagnostic and safety assessment;
5. discussing treatment choices, which may include no medication, a non-controlled prescription, therapy, testing, or referral to in-person care;
6. sending an appropriate prescription to a pharmacy; and
7. arranging follow-up based on the medicine, diagnosis, response, and state requirements.

The questionnaire is not the diagnosis. Tools such as the PHQ-9 and GAD-7 can quantify depression and anxiety symptoms, but positive screens require clinical interpretation [2][3]. Likewise, the six-item Adult ADHD Self-Report Scale is a screening tool, not proof of ADHD and not an entitlement to a prescription [4].

What Happens During a Medication Visit

A careful first visit should verify the symptom timeline, prior treatment, current medicines, allergies, pregnancy status when relevant, substance use, medical conditions, and immediate safety concerns. The clinician may ask how symptoms affect more than one setting and whether sleep, anxiety, depression, trauma, medications, or a medical condition better explains them.

For medication decisions, useful questions include:

• What diagnosis is being considered, and what alternatives were ruled out?
• What outcome will show that treatment is working?
• What common and serious adverse effects should I watch for?
• What measurements or laboratory tests are needed?
• When is the next follow-up?
• What should I do if symptoms worsen before then?
• Is the clinician in network, and is the medication itself covered?

A prescription is not guaranteed on the first visit or any later visit. A clinician may need prior records, vital signs, laboratory results, collateral history, or an in-person examination before prescribing.

Can Cerebral Prescribe Adderall or Other Controlled Substances?

No current review should tell patients that Cerebral routinely prescribes Adderall or other controlled substances.

The U.S. Department of Justice announced in November 2024 that Cerebral entered a non-prosecution agreement and agreed to pay more than $3.6 million in connection with practices that encouraged unauthorized distribution of controlled substances between 2019 and 2022. The agreement records that Cerebral stopped prescribing controlled substances to all patients on October 15, 2022 and agreed not to prescribe controlled substances in the future [5].

This company-specific restriction is separate from the general federal telemedicine rules. DEA and HHS extended certain pandemic-era telemedicine flexibilities through December 31, 2026, allowing eligible DEA-registered clinicians to prescribe some controlled medications without a prior in-person examination when all federal and state requirements are met [6]. That broader rule does not override Cerebral's own agreement.

If ADHD is the reason for seeking care, ask Cerebral before paying whether it currently provides ADHD assessment in your state and which non-controlled treatments it can manage. Evidence-based ADHD care can include behavioral treatment and non-controlled medicines, but the appropriate choice depends on a complete assessment.

What Medications Might Be Considered?

Medication selection depends on the diagnosis, contraindications, prior response, other medicines, and clinician judgment. For depression and anxiety, commonly used non-controlled options include SSRIs, SNRIs, buspirone, and other antidepressants. For ADHD, non-controlled prescription options include atomoxetine and viloxazine extended-release; some alpha-2 agonists are approved for pediatric ADHD and may be used in other circumstances based on clinician judgment.

Do not assume every Cerebral clinician offers every medicine or treats every condition. State scope-of-practice rules, clinician training, service exclusions, and patient-specific safety needs may narrow the options.

Insurance, Price, and Pharmacy Questions

Cerebral advertises enrollment with or without insurance, but network participation is not the same as a promise that a specific plan will pay. Before authorizing a recurring charge:

• confirm the clinician and service are in network;
• ask whether the first visit and follow-ups have different cost-sharing;
• ask whether the platform fee is separate from billed clinical visits;
• check whether medication is billed separately at the pharmacy;
• confirm the renewal date and current cancellation method;
• save the enrollment terms and cancellation confirmation.

Prescription coverage is determined by the pharmacy benefit, not merely by whether the visit is covered. A pharmacy may also require clarification or decline to dispense a prescription after its own safety and legal review.

Cerebral's Regulatory and Privacy History

Two federal actions are material when evaluating the service.

Controlled-substance prescribing

The 2024 Department of Justice agreement resolved an investigation into practices from 2019 through 2022. The government said Cerebral had used prescribing metrics and practices that could encourage unnecessary controlled-substance prescriptions. Cerebral entered a non-prosecution agreement, paid more than $3.6 million, and agreed to compliance obligations and the continuing controlled-substance restriction [5].

Privacy, data security, and cancellation

In 2024, the Federal Trade Commission alleged that Cerebral disclosed sensitive health and personal information to advertising platforms, failed to adequately secure data, and made cancellation difficult while continuing some charges. Cerebral agreed to an order restricting use of health information for advertising, requiring a privacy and security program, simplifying cancellation, and providing more than $7 million in payments and refunds. In May 2025, the FTC announced more than $5 million in refunds to over 40,000 affected consumers [7][8].

These actions concern past conduct and binding remedies; they do not prove the quality of an individual clinician's current care. They are nevertheless relevant to an informed choice. Review the current privacy notice, use a unique password, enable available account protections, and retain cancellation records.

Is Telepsychiatry Effective?

Telehealth is a care-delivery method, not a single treatment. Evidence supports video-delivered mental-health care for several outpatient uses, but results depend on the condition, intervention, clinician, technology, and patient needs.

A systematic review of videoconferencing psychotherapy found meaningful evidence for depression treatment, while also noting variation among studies [9]. A review of telemedicine in ADHD described potential access benefits but did not establish that every direct-to-consumer platform, assessment process, or prescribing model is equivalent to comprehensive in-person care [10].

Telehealth may be a good fit when:

• the condition can be assessed reliably by history and video;
• the patient has privacy and stable internet access;
• vital signs, laboratory testing, and in-person examination can be obtained when needed;
• the platform provides continuity and clear escalation routes; and
• the treatment falls within the clinician's scope and the platform's services.

In-person or higher-acuity care may be needed for immediate safety concerns, severe or rapidly worsening symptoms, diagnostic uncertainty requiring physical or neurologic examination, complex substance use, or medicines requiring close laboratory and physical monitoring.

How to Evaluate Cerebral Before Enrolling

Check the current answers to these questions on Cerebral's site or with support:

1. Is the requested service available in my state?
2. What license and specialty does the assigned clinician hold?
3. Is that clinician in my insurance network?
4. What is charged today, what renews, and when?
5. How do I cancel, and when does cancellation take effect?
6. How are prescriptions, refills, after-hours questions, and adverse effects handled?
7. How can I obtain or transfer my records?
8. What data are collected, and which third parties receive them?
9. What happens if the clinician decides telehealth is not appropriate?

The strongest reason to choose any service is not speed alone. It is a good match between the clinical need, qualified clinician, continuity plan, privacy expectations, and total cost.